These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 11530127)
21. Atorvastatin therapy decreases androstenedione and dehydroepiandrosterone sulphate concentrations in patients with polycystic ovary syndrome: randomized controlled study. Sathyapalan T; Smith KA; Coady AM; Kilpatrick ES; Atkin SL Ann Clin Biochem; 2012 Jan; 49(Pt 1):80-5. PubMed ID: 21972424 [TBL] [Abstract][Full Text] [Related]
22. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome. Thierry van Dessel HJ; Lee PD; Faessen G; Fauser BC; Giudice LC J Clin Endocrinol Metab; 1999 Sep; 84(9):3030-5. PubMed ID: 10487660 [TBL] [Abstract][Full Text] [Related]
23. Relationship between body fat distribution and bone mineral density in premenopausal Japanese women. Douchi T; Yamamoto S; Oki T; Maruta K; Kuwahata R; Nagata Y Obstet Gynecol; 2000 May; 95(5):722-5. PubMed ID: 10775737 [TBL] [Abstract][Full Text] [Related]
24. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features. Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538 [TBL] [Abstract][Full Text] [Related]
25. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Holte J; Bergh T; Gennarelli G; Wide L Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458 [TBL] [Abstract][Full Text] [Related]
26. Resistance Exercise Impacts Lean Muscle Mass in Women with Polycystic Ovary Syndrome. Kogure GS; Miranda-Furtado CL; Silva RC; Melo AS; Ferriani RA; De Sá MF; Dos Reis RM Med Sci Sports Exerc; 2016 Apr; 48(4):589-98. PubMed ID: 26587847 [TBL] [Abstract][Full Text] [Related]
27. Plasma thiols and androgen levels in polycystic ovary syndrome. Vrbíková J; Tallová J; Biciková M; Dvoráková K; Hill M; Stárka L Clin Chem Lab Med; 2003 Feb; 41(2):216-21. PubMed ID: 12667010 [TBL] [Abstract][Full Text] [Related]
28. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism. Rittmaster RS; Thompson DL J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885 [TBL] [Abstract][Full Text] [Related]
29. The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome. Yucel A; Noyan V; Sagsoz N Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):81-6. PubMed ID: 16337726 [TBL] [Abstract][Full Text] [Related]
30. Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters. Chapman IM; Wittert GA; Norman RJ Clin Endocrinol (Oxf); 1997 Feb; 46(2):175-81. PubMed ID: 9135699 [TBL] [Abstract][Full Text] [Related]
31. Body composition, sex steroids, IGF-1, and bone mineral status in aging men. Ravaglia G; Forti P; Maioli F; Nesi B; Pratelli L; Cucinotta D; Bastagli L; Cavalli G J Gerontol A Biol Sci Med Sci; 2000 Sep; 55(9):M516-21. PubMed ID: 10995049 [TBL] [Abstract][Full Text] [Related]
32. The association of body mass index and biochemical hyperandrogenaemia in women with and without polycystic ovary syndrome. Yasmin E; Balen AH; Barth JH Eur J Obstet Gynecol Reprod Biol; 2013 Feb; 166(2):173-7. PubMed ID: 23102586 [TBL] [Abstract][Full Text] [Related]
33. Sex hormone status and bone mineral density in men with rheumatoid arthritis. Mateo L; Nolla JM; Bonnin MR; Navarro MA; Roig-Escofet D J Rheumatol; 1995 Aug; 22(8):1455-60. PubMed ID: 7473465 [TBL] [Abstract][Full Text] [Related]
34. Body composition, bone mineral density and fractures in late postmenopausal women with polycystic ovary syndrome - a long-term follow-up study. Schmidt J; Dahlgren E; Brännström M; Landin-Wilhelmsen K Clin Endocrinol (Oxf); 2012 Aug; 77(2):207-14. PubMed ID: 22385110 [TBL] [Abstract][Full Text] [Related]
35. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels. Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364 [TBL] [Abstract][Full Text] [Related]
36. Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients. Ambroziak U; Kuryłowicz A; Kępczyńska-Nyk A; Bartoszewicz Z; Kondracka A; Jaźwiec R; Samborowska E; Dadlez M; Wysłouch-Cieszyńska A; Bednarczuk T Ginekol Pol; 2017; 88(1):5-8. PubMed ID: 28157253 [TBL] [Abstract][Full Text] [Related]
37. Disruption of the synchronous secretion of leptin, LH, and ovarian androgens in nonobese adolescents with the polycystic ovarian syndrome. Veldhuis JD; Pincus SM; Garcia-Rudaz MC; Ropelato MG; Escobar ME; Barontini M J Clin Endocrinol Metab; 2001 Aug; 86(8):3772-8. PubMed ID: 11502810 [TBL] [Abstract][Full Text] [Related]
38. Comparison of adrenocortical steroidogenesis in women with post-adolescent severe acne and polycystic ovary syndrome. Cinar N; Cetinozman F; Aksoy DY; Elcin G; Yildiz BO J Eur Acad Dermatol Venereol; 2015 May; 29(5):875-80. PubMed ID: 25176476 [TBL] [Abstract][Full Text] [Related]
39. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level. Azziz R; Black VY; Knochenhauer ES; Hines GA; Boots LR J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576 [TBL] [Abstract][Full Text] [Related]
40. Low calcium intake is associated with decreased adrenal androgens and reduced bone age in premenarcheal girls in the last pubertal stages. Bonofiglio D; Garofalo C; Catalano S; Marsico S; Aquila S; Andò S J Bone Miner Metab; 2004; 22(1):64-70. PubMed ID: 14691690 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]